171 related articles for article (PubMed ID: 30321704)
1. Association of TAFI gene polymorphisms with severity of coronary stenosis in stable coronary artery disease.
Rattanawan C; Komanasin N; Settasatian N; Settasatian C; Kukongviriyapan U; Intharapetch P; Senthong V
Thromb Res; 2018 Nov; 171():171-176. PubMed ID: 30321704
[TBL] [Abstract][Full Text] [Related]
2. Influence of thrombin-activatable fibrinolysis inhibitor and plasminogen activator inhibitor-1 gene polymorphisms on tissue-type plasminogen activator-induced recanalization in ischemic stroke patients.
Fernandez-Cadenas I; Alvarez-Sabin J; Ribo M; Rubiera M; Mendioroz M; Molina CA; Rosell A; Montaner J
J Thromb Haemost; 2007 Sep; 5(9):1862-8. PubMed ID: 17723126
[TBL] [Abstract][Full Text] [Related]
3. Fibrinolysis inhibitors in plaque stability: a morphological association of PAI-1 and TAFI in advanced carotid plaque.
Jönsson Rylander AC; Lindgren A; Deinum J; Bergström GM; Böttcher G; Kalies I; Wåhlander K
J Thromb Haemost; 2017 Apr; 15(4):758-769. PubMed ID: 28135035
[TBL] [Abstract][Full Text] [Related]
4. Thrombin-activatable fibrinolysis inhibitor genetic polymorphisms as markers of the type of acute coronary syndrome.
Tàssies D; Roqué M; Monteagudo J; Martorell T; Sionis A; Arzamendi D; Heras M; Reverter JC
Thromb Res; 2009 Nov; 124(5):614-8. PubMed ID: 19699511
[TBL] [Abstract][Full Text] [Related]
5. Thrombin-activatable fibrinolysis inhibitor in young patients with myocardial infarction and its relationship with the fibrinolytic function and the protein C system.
Zorio E; Castelló R; Falcó C; España F; Osa A; Almenar L; Aznar J; Estellés A
Br J Haematol; 2003 Sep; 122(6):958-65. PubMed ID: 12956767
[TBL] [Abstract][Full Text] [Related]
6. Haplotypes of TAFI gene and the risk of cerebral venous thrombosis--a case-control study.
Orikaza CM; Morelli VM; Matos MF; Lourenço DM
Thromb Res; 2014 Jan; 133(1):120-4. PubMed ID: 24252537
[TBL] [Abstract][Full Text] [Related]
7. PAI-1 4G/5G polymorphism and plasma levels association in patients with coronary artery disease.
Lima LM; Carvalho Md; Fonseca Neto CP; Garcia JC; Sousa MO
Arq Bras Cardiol; 2011 Dec; 97(6):462-389. PubMed ID: 22011808
[TBL] [Abstract][Full Text] [Related]
8. Thrombin-activatable fibrinolysis inhibitor (TAFI) levels and its polymorphism rs3742264 are associated with dyslipidemia in a cohort of Brazilian subjects.
Santos IR; Fernandes AP; Carvalho MG; Sousa MO; Ferreira CN; Gomes KB
Clin Chim Acta; 2014 Jun; 433():76-83. PubMed ID: 24631134
[TBL] [Abstract][Full Text] [Related]
9. Central nervous system bleeding in pediatric patients with factor XIII deficiency: a study on 23 new cases.
Naderi M; Alizadeh S; Kazemi A; Tabibian S; Zaker F; Bamedi T; Kashani Khatib Z; Dorgalaleh A
Hematology; 2015 Mar; 20(2):112-8. PubMed ID: 25001244
[TBL] [Abstract][Full Text] [Related]
10. [Study on the association of thrombin activatable fibrinolysis inhibitor and the Thr325Ile and Thr147Ala polymorphisms of its encoding gene CPB2 in patients with coronary heart disease].
Xu CW; Wang LL; Wu XB; Zhao JJ; Du YM; Jiang CY
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Aug; 25(4):438-42. PubMed ID: 18683146
[TBL] [Abstract][Full Text] [Related]
11. TAFI gene haplotypes, TAFI plasma levels and future risk of coronary heart disease: the PRIME Study.
Morange PE; Tregouet DA; Frere C; Luc G; Arveiler D; Ferrieres J; Amouyel P; Evans A; Ducimetiere P; Cambien F; Tiret L; Juhan-Vague I;
J Thromb Haemost; 2005 Jul; 3(7):1503-10. PubMed ID: 15978108
[TBL] [Abstract][Full Text] [Related]
12. The association of functional polymorphisms in genes encoding growth factors for endothelial cells and smooth muscle cells with the severity of coronary artery disease.
Osadnik T; Strzelczyk JK; Lekston A; Reguła R; Bujak K; Fronczek M; Gawlita M; Gonera M; Wasilewski J; Szyguła-Jurkiewicz B; Gierlotka M; Gąsior M
BMC Cardiovasc Disord; 2016 Nov; 16(1):218. PubMed ID: 27835972
[TBL] [Abstract][Full Text] [Related]
13. Plasma thrombin-activatable fibrinolysis inhibitor and the 1040C/T polymorphism are risk factors for diabetic kidney disease in Chinese patients with type 2 diabetes.
Huang Q; Feng D; Pan L; Wang H; Wu Y; Zhong B; Gong J; Lin H; Fei X
PeerJ; 2023; 11():e16352. PubMed ID: 38025709
[TBL] [Abstract][Full Text] [Related]
14. Assessment of plasminogen activator inhibitor-1(PAI1) and thrombin activitable fibrinolysis inhibitor (TAFI) in Egyptian children with hemophilia A.
Soliman M; Osman N; Hefnawy S; El Hawy MA
Pediatr Hematol Oncol; 2022 May; 39(4):318-328. PubMed ID: 34668834
[TBL] [Abstract][Full Text] [Related]
15. Thrombin activatable fibrinolysis inhibitor plasma levels and TAFI Thr325Ile genetic polymorphism in a cohort of Egyptian sickle cell disease patients and impact on disease severity.
Hamdy M; Shaheen IA; Khallaf M; Selim YMM
Pediatr Blood Cancer; 2024 Jun; 71(6):e30959. PubMed ID: 38520679
[TBL] [Abstract][Full Text] [Related]
16. Plasma thrombin-activatable fibrinolysis inhibitor levels and Thr325Ile polymorphism as a risk marker of myocardial infarction in Egyptian patients.
Kamal HM; Ahmed AS; Fawzy MS; Mohamed FA; Elbaz AA
Acta Cardiol; 2011 Aug; 66(4):483-8. PubMed ID: 21894805
[TBL] [Abstract][Full Text] [Related]
17. Thrombin-activatable fibrinolysis inhibitor polymorphisms and recurrent pregnancy loss.
Masini S; Ticconi C; Gravina P; Tomassini M; Pietropolli A; Forte V; Federici G; Piccione E; Bernardini S
Fertil Steril; 2009 Aug; 92(2):694-702. PubMed ID: 18774564
[TBL] [Abstract][Full Text] [Related]
18. Impact of genetic polymorphisms in thrombin activatable fibrinolysis inhibitor (TAFI) on venous thrombosis disease: A meta-analysis.
Qian K; Xu J; Wan H; Fu F; Lu J; Lin Z; Liu Z; Liu H
Gene; 2015 Sep; 569(2):173-81. PubMed ID: 26071134
[TBL] [Abstract][Full Text] [Related]
19. Genetic and environmental influences on the fibrinolytic system: a twin study.
Peetz D; Victor A; Adams P; Erbes H; Hafner G; Lackner KJ; Hoehler T
Thromb Haemost; 2004 Aug; 92(2):344-51. PubMed ID: 15269831
[TBL] [Abstract][Full Text] [Related]
20. Plasma thrombin-activatable fibrinolysis inhibitor antigen concentration and genotype in relation to myocardial infarction in the north and south of Europe.
Juhan-Vague I; Morange PE; Aubert H; Henry M; Aillaud MF; Alessi MC; Samnegård A; Hawe E; Yudkin J; Margaglione M; Di Minno G; Hamsten A; Humphries SE;
Arterioscler Thromb Vasc Biol; 2002 May; 22(5):867-73. PubMed ID: 12006404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
